Supplementary Methods S8 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Methods 8. Immune subtype and related number of genes profiled using the NanoString PanCancer Immune panel.
Supplementary Methods S8 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study | Synapse